(ACAN) Acanthe Développement - Ratings and Ratios
Office, Real, Estate, Properties
Description: ACAN Acanthe Développement
Acanthe Développement is a French real estate investment company listed on Euronext Paris, operating within the Office REITs sub-industry. With its registered office in Paris, the company has established itself as a significant player in the European property market.
Analyzing the companys financials and market performance, its evident that Acanthe Développement has a market capitalization of €54.55M. The Return on Equity (RoE) stands at 98.55%, indicating a highly efficient use of shareholder equity. However, the absence of Price-to-Earnings (P/E) ratios suggests that the company may not be generating earnings or is not profitable on a net income basis.
From a technical standpoint, Acanthe Développements stock is currently trading at €0.32, with its 20-day and 50-day Simple Moving Averages (SMA) converging at the same level, indicating a stable short-term trend. The 200-day SMA is slightly higher at €0.34, suggesting a potential resistance level. The Average True Range (ATR) is €0.02, representing a volatility of 4.87%, which is relatively moderate.
Given the current technical and fundamental data, a forecast for Acanthe Développement can be constructed. The stocks current price is near its 52-week low, and with the SMA20 and SMA50 being equal, it may indicate a consolidation phase. If the company can maintain its RoE and potentially improve its earnings, the stock could see an upward revaluation. However, the lack of P/E ratios and forward-looking earnings data introduces uncertainty. Assuming a potential breakout above the 200-day SMA (€0.34), the stock could target the 52-week high of €0.38. Conversely, a failure to break through this resistance could lead to a retest of the 52-week low at €0.29. Therefore, a cautious approach is warranted, with a potential buy signal emerging upon a sustained move above €0.34, targeting €0.38, while a stop-loss could be considered around €0.29 to limit potential downside.
ACAN Stock Overview
| Market Cap in USD | 60m |
| Sub-Industry | Office REITs |
| IPO / Inception |
ACAN Stock Ratings
| Growth Rating | -0.96% |
| Fundamental | 52.6% |
| Dividend Rating | 4.98% |
| Return 12m vs S&P 500 | -27.6% |
| Analyst Rating | - |
ACAN Dividends
Currently no dividends paidACAN Growth Ratios
| Growth Correlation 3m | -27.7% |
| Growth Correlation 12m | -45.8% |
| Growth Correlation 5y | 58.9% |
| CAGR 5y | 3.52% |
| CAGR/Max DD 5y | 0.10 |
| Sharpe Ratio 12m | -0.10 |
| Alpha | -21.56 |
| Beta | -0.074 |
| Volatility | 24.39% |
| Current Volume | 4.8k |
| Average Volume 20d | 13k |
| Stop Loss | 0.3 (-3.2%) |
| Signal | 0.00 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (131.6m TTM) > 0 and > 6% of Revenue (6% = 390.1k TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 147.9% (prev 980.2%; Δ -832.3pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 5.88m <= Net Income 131.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (198.0m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 55.41% (prev 70.99%; Δ -15.58pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.82% (prev 2.77%; Δ 2.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1558 (EBITDA TTM -7.18m / Interest Expense TTM 5000 ) >= 6 (WARN >= 3) |
Altman Z'' 1.79
| (A) 0.07 = (Total Current Assets 18.3m - Total Current Liabilities 8.64m) / Total Assets 132.8m |
| (B) -0.03 = Retained Earnings (Balance) -3.97m / Total Assets 132.8m |
| (C) -0.06 = EBIT TTM -7.79m / Avg Total Assets 135.0m |
| (D) 1.72 = Book Value of Equity 35.4m / Total Liabilities 20.6m |
| Total Rating: 1.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.61
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 9.79% = 4.89 |
| 3. FCF Margin 86.86% = 7.50 |
| 4. Debt/Equity 0.12 = 2.49 |
| 5. Debt/Ebitda -1.83 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE 106.8% = 2.50 |
| 8. Rev. Trend -55.85% = -2.79 |
| 9. Rev. CAGR -24.97% = -2.50 |
| 10. EPS Trend -79.56% = -1.99 |
| 11. EPS CAGR -36.35% = -2.50 |
What is the price of ACAN shares?
Over the past week, the price has changed by +0.00%, over one month by -6.06%, over three months by -1.90% and over the past year by -16.89%.
Is Acanthe Développement a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACAN is around 0.29 EUR . This means that ACAN is currently overvalued and has a potential downside of -6.45%.
Is ACAN a buy, sell or hold?
What are the forecasts/targets for the ACAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.3 | 0% |
ACAN Fundamental Data Overview
Market Cap EUR = 51.3m (51.3m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 6.74m EUR (Cash And Short Term Investments, last quarter)
P/S = 13.0732
P/B = 0.4568
Beta = 0.388
Revenue TTM = 6.50m EUR
EBIT TTM = -7.79m EUR
EBITDA TTM = -7.18m EUR
Long Term Debt = 12.0m EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.20m EUR (from shortTermDebt, last quarter)
Debt = 13.2m EUR (Calculated: Short Term 1.20m + Long Term 12.0m)
Net Debt = -5.48m EUR (from netDebt column, last quarter)
Enterprise Value = 57.7m EUR (51.3m + Debt 13.2m - CCE 6.74m)
Interest Coverage Ratio = -1558 (Ebit TTM -7.79m / Interest Expense TTM 5000 )
FCF Yield = 9.79% (FCF TTM 5.65m / Enterprise Value 57.7m)
FCF Margin = 86.86% (FCF TTM 5.65m / Revenue TTM 6.50m)
Net Margin = 2024 % (Net Income TTM 131.6m / Revenue TTM 6.50m)
Gross Margin = 55.41% ((Revenue TTM 6.50m - Cost of Revenue TTM 2.90m) / Revenue TTM)
Tobins Q-Ratio = 1.63 (Enterprise Value 57.7m / Book Value Of Equity 35.4m)
Interest Expense / Debt = 0.04% (Interest Expense 5000 / Debt 13.2m)
Taxrate = 1114 % (set to none) (from quarterly Income Tax Expense: 1.89m / 170.0k)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.11 (Total Current Assets 18.3m / Total Current Liabilities 8.64m)
Debt / Equity = 0.12 (Debt 13.2m / last Quarter total Stockholder Equity 112.2m)
Debt / EBITDA = -1.83 (Net Debt -5.48m / EBITDA -7.18m)
Debt / FCF = 2.33 (Debt 13.2m / FCF TTM 5.65m)
Total Stockholder Equity = 123.2m (last 4 quarters mean)
RoA = 99.07% (Net Income 131.6m, Total Assets 132.8m )
RoE = 106.8% (Net Income TTM 131.6m / Total Stockholder Equity 123.2m)
RoCE = -5.76% (Ebit -7.79m / (Equity 123.2m + L.T.Debt 12.0m))
RoIC = unknown (NOPAT none, Invested Capital 124.3m, Ebit -7.79m)
WACC = unknown (E(51.3m)/V(64.4m) * Re(5.74%)) + (D(13.2m)/V(64.4m) * Rd(0.04%) * (1-Tc(none)))
Shares Correlation 5-Years: 70.0 | Cagr: 9.47%
Discount Rate = 5.74% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈5.22m ; Y1≈6.44m ; Y5≈11.0m
Fair Price DCF = 1.13 (DCF Value 186.7m / Shares Outstanding 165.4m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: -55.85 | Revenue CAGR: -24.97%
Rev Growth-of-Growth: 16.86
EPS Correlation: -79.56 | EPS CAGR: -36.35%
EPS Growth-of-Growth: -204.3